Professor Ann Ager
Professor of Cellular Immunity and Immunotherapy, Division of Infection and Immunity and Systems Immunity Research Institute
- agera@cardiff.ac.uk
- +44 (0)29 2068 8872
- 3F08, Henry Wellcome Building for Biomedical Research, University Hospital of Wales, Heath Park, Cardiff, CF14 4XN
Overview
I am a cellular immunologist with more than 30 years’ experience studying how T- cells move around the body to maintain healthy tissues and control diseases such as infections, cancer, and neurodegeneration.
T-cells continually survey the body by moving in and out of lymphoid organs where signs of disease or tissue damage are detected. Following activation, T-cells relocate via the bloodstream from lymphoid organs and home to the diseased organ where they can control the disease.
Our studies of T-cell trafficking have revealed novel approaches to boost immunity and protect our bodies against virus infections and cancers by increasing T-cell homing to diseased tissues.
As Chair Forum and a Trustee of the British Society for Immunology (BSI) and Council member of the International Union of Immunological Societies (IUIS), Ann is an advocate for Immunology to governments and other policymakers.
Biography
Career Summary
I gained a PhD from Cambridge University studying inflammatory responses in vascular endothelial cells and trained in microvascular endothelial cell biology with Professor Judah Folkman at Harvard Medical School during my post-doctoral studies. In 1983 I moved to the Department of Immunology, University of Manchester as a postdoctoral fellow working with Professor Bill Ford and started what has become my life-long interests in specialised high endothelial venule (HEV) blood vessels and T-cell homing in health and disease. I gained an MRC Senior Fellowship in Manchester before moving to a Principal Investigator position at the MRC National Institute for Medical Research, London in 1992 where I began working on L-selectin/CD62L. In 2007 I moved to the Division of Infection and Immunity, Cardiff University as a Reader and was awarded a personal chair in 2018. Since moving to Cardiff, my research has focussed on T-cell trafficking in diseases such as virus infection, cancer, and Alzheimer’s disease.
Current appointment:
2018 - Professor of Cellular Immunity and Immunotherapy, Infection and Immunity, Cardiff University
Honours and awards
1979 - 1980 BHF Travelling Fellow, Childrens’ Hosptial, Harvard Medical School, USA
2015-2018 President, UK Cell Adhesion Society (elected)
2019- 2022 British Society for Immunology, Chair of Forum (elected)
2019- 2022 British Society for Immunology, Member of Board of Trustees (elected)
2019- 2022 National Cancer Research Institute-British Society of Immunology Strategic Alliance, Deputy Chair
Professional memberships
Member of the British Society for Immunology
Founding member of the UK Cell Adhesion Society
Member of Cardiff Institute for Tissue Engineering and Repair (CITER)
Academic positions
B2007- 2018 Reader, Infection and Immunity, School of Medicine, Cardiff University
1992 - 2007 Senior Scientist, Division of Cellular Immunology, MRC National Institute for Medical Research,
1987 - 1992 MRC Senior Fellow, Immunology Department, University of Manchester
1983 - 1987 MRC Post-doctoral Fellow, Immunology Department, University of Manchester
1980 - 1983 BBSRC Post-doctoral Fellow, Department of Cell Biology, The Babraham Institute
Speaking engagements
Invited Speaker: Translating Tumour Immunotherapy | British Society for Immunology Virtual Conference: ‘Connecting Immunology in the time of Covid-19’ | Dec 2020 |
Invited Faculty and Moderator | International Union of Immunological Societies Covid 19 webinar series | July 2020 |
Invited Chair: Optimising T cell homing | Onco Cell Therapy Virtual Summit | July 2020 |
Invited Speaker: Manipulating Homing and Activation of T-Cells to Improve Adoptive Cell Therapy for Cancer | 5th Annual Immuno-Oncology Summit Europe | March 2020 |
Invited Speaker: L-selectin enhanced T-cells and their impact on cancer immunotherapy | 4th Annual CAR-T Congress EU | Jan 2020 |
Invited Faculty and Chair: Adoptive T cell therapy | 17th International Congress of Immunology, Beijing, China | Oct 2019 |
Invited Faculty and Speaker: Altered Immune Surveillance in Inherited Cancers | Collaborative Group of the Americas on Gastrointestinal Cancer | Nov 2019 |
Invited speaker: Understanding peripheral immune cell-blood brain barrier cross-talk in dementia | ARUK Regional Meeting, Exeter, | June 2019 |
Invited Faculty and Speaker: Lymphocyte homing: getting lymphocytes to the right place at the right time | Henry Stewart Talks on Immunology | 2019 |
Invited Speaker: Directing the Traffic of Effector Lymphocytes: Breaking Down Dogma | Sun-Yat Sen University, Guangzhou, China | Oct 2017 |
Invited Visiting Scientist and Speaker: Directing the traffic of T lymphocytes for effective cancer immunotherapy | Applied Tumour Biology Department, University Hospital of Heidelberg, Germany | Nov 2017 |
Scientific Organising Committee: The Many Facets of Inflammation | Joint meeting of the UK Cell Adhesion Society and British Microcirculation Society, Birmingham, UK | Apr 2017 |
Invited Speaker: Pros and Cons of Cancer Immunotherapies | Cancer Council New South Wales, Lowy Cancer Centre, Sydney, Australia | Mar 2017 |
Invited Speaker: Regulating L-selectin expression during T cell homing: Getting to the right place at the right time | Haematology Department, Monash University, Melbourne, Australia | Mar 2017 |
Invited Expert | Special Interest Group, Cell and Gene Therapy, Welsh Government | 2017- |
Research Committee Member | Cardiff Institute for Tissue Engineering and Repair | 2016-2018 |
Invited Chair and Speaker: Mapping Changes to Vascular Health in Alzheimer's Disease: The Role of EPHA1 Risk Alleles | Alzheimer’s Association International Conference, Toronto | Jul 2016 |
Invited Plenary speaker: T lymphocyte homing in adoptive cell therapies for solid cancers | Biochemical Society: Chimeric Antigen Receptor therapy in Haematology and Oncology: Current Successes and Challenges, London | Sept 2015 |
Invited expert: Manipulating T lymphocyte homing to improve cancer immunotherapies | Adoptive T-cell Therapy Congress, Kisaco Research, London | Mar 2015 |
Publications
We are currently unable to retrieve the list of publications. Visit our institutional repository.Teaching
External lectures:
Ager, A. (2020, October 29). Lymphocyte homing: getting lymphocytes to the right place at the right time. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. https://hstalks.com/bs/4445/.
Taught courses:
- Deliver Student Selected Component (SSC) in Interactive Immunology to 2nd and 3rd year medical students (lead laboratory sessions, review student presentation, deliver lectures).
- Deliver 3rd year BSc and Medical Intercalated Degree students in Pharmacology and Pathology (supervised 7 students’ laboratory projects; best project by Louise Rogers, 2017. Danial Saree, 2019)
- Deliver taught Masters in Research (supervised 6 students and recruited one, Andrew Newman to study for a PhD under my supervision)
- Develop teaching skills of my PhD students and PDRAs by supporting their supervision of final year B.Sc. project students in a co-supervisory role.
Examining experience:
- External examiner for Manchester University’s Master degrees in Immunology and Immunogenetics, (15-20 students p.a.) and Immunology by distance learning (5-10 students p.a.) 2012-2016
- External examiner of PhD theses for the Universities of Birmingham, Bristol, Dundee, Glasgow, Imperial College London, KCL, Oxford, Sheffield, Toronto and Australian National University
T-cell homing in health and disease
A major focus is the regulation of the homing receptor, L-selectin/CD62L, on T-cells and its impact on T-cell homing via specialized high endothelial venule (HEV) blood vessels.
Unique reagents, experimental animal models and cell-based assays have been developed in the Ager lab and shown that the role of L-selectin on disease-infiltrating T-cells has been overlooked because of its’ instability in the T-cell membrane due to proteolytic ectodomain shedding by ADAM17 metalloproteinase.
Our work has revealed that L-selectin is essential to deliver killer T- cells to influenza-infected lungs for protective immunity http://www.bbc.co.uk/news/uk-wales-south-east-wales-35373730 . Moreover, our studies have revealed new roles for L-selectin in T-cell immunity to cancers which are not related to T-cell homing.
Major goals for the future are to identify the mechanisms underlying L-selectin dependent anti-viral and anti-tumour immunity and whether this is dependent on HEV neogenesis in the diseased organ.
New research aims to determine if T-cell homing contributes to neurodegeneration such as in Alzheimer’s disease
Current Projects
- The regulation of protective immunity to influenza viruses by L-selectin
- The translational potential of arming CAR T-cells with L-selectin for treating cancer patients
- The role of T-cells in blood-brain barrier breakdown in dementia
Current Grant Funding:
1. Wellcome Trust ISSF Translational Kickstart Award "Translating L-selectin enhancement to clinically relevant T-cell based cancer immunotherapies" Lead PI (Mar 2021-Jun 2022) £49,950
2. BBSRC Project Grant "The Regulation of Protective Immunity to Viruses by L-selectin" Lead PI (Jan 2019-Dec 2022). Co-PI, Dr Vera Knäuper, £686,195
3. CR-UK Project Grant "Unravelling the relationship between T cell trafficking and cancer immunotherapy" Lead PI (Nov 2017-Dec 2021) £289,000.
4. Sir Geraint Evans Cardiovascular Research Fund Project Grant “Dissecting interactions between peripheral immune cells and the blood-brain barrier in dementia Lead PI (Nov 2019-Mar 2021). Co-PI. Professor Anne Ridley, £49,544
5. BBSRC CASE PhD studentship with GlaxoSmithKline "Dissecting the relationship between phosphinositide3-kinase δ activity and L-selectin expression by leucocytes" Lead PI (Oct 2018-Sept 2022). Co-PI, Dr Augustin Amour.
6. UK Dementia Research Institute PhD studentship "Mapping the role of EphA1 risk variants in Alzheimer’s disease" Lead PI (Oct 2018-Mar 2022).
7. Tuberous Sclerosis Society PhD studentship "Targeting the Ref1/STAT3 axis to treat Tuberous Sclerosis" Co- I (Oct 2018-Sept 2022). Lead PI: Professor Andy Tee
External Collaborations
Professor Erwei Song, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China
Dr Meng Huee Lee, Xian Jiaotong Liverpool University, Suzhou, China
Professor Joseph Skitzki, Rosewell Park Comprehensive Cancer Center, Buffalo, USA
Professor Stephen Turner, Biomedical Discovery Institute, Monash University, Australia
Professor Sharon Evans, Rosewell Park Comprehensive Cancer Center, Buffalo, USA
Professor Anne Ridley, University of Bristol
Dr Michael May, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, USA
Supervision
- T lymphocyte homing in health and disease
- Lymphocyte-blood vessel interactions in lymphoid organs and inflamed tissues
- The role of blood brain barrier in neurodegeneration
- Therapeutic manipulation of T lymphocyte homing to boost immunity to viruses and cancer
Past projects
PGR Students
2018- Jesse Champion ( Co-supervisor)
2018- Lauren Thorburn
2018- Sophie Reed
2017- Hanan Almutairi (Co-supervisor)
2017- Abdullah Alanazi
2017- Owen Moon
2015- Helen Owens
2013- Andrew Newman
2013- Ellyn Hughes (Co-supervisor)
2012- Emily Colbeck (Co-supervisor))
2012- Diana Filipa Costa Bento (Co-supervisor)
2012- Rebar Mohammed, Cardiff University
2011- Sophie Wehenkel, Cardiff University
2009 – Katarzyna Gawel, Cardiff University (with Dr Vera Knauper)
2002 – 2006 Owen McGuinn, PhD, University of Cambridge (with Prof. Gillian Murphy and Dr Peter Newham)
1997 - 2002 Emma-Kate Yates, Ph.D.
1998 - 2002 Stephen Jolles, Ph.D., University of London
1997 - 2000 Rhian Phillips, Ph.D., University of London
1996 - 1999 Kyriakos Tanousis, Ph.D., University of London
1993 - 1996 Abigail Price, Ph.D., University of London
1990 - 1993 Mary di Mauro, Ph.D., University of Manchester
1989 - 1990 Michael May, M.Sc., University of Manchester
Engagement
2021 'How COVID-19 vaccines work' in public meeting organised by EMWWH and the Learned Society for Wales
2020 I’m A Scientist, Health Zone STEM engagement activity connecting schools students with scientists
2020 Coordinated meeting of the British Society for Immunology and the Chief Scientific Advisor (Health) for Wales to discuss Wales’ experience and practice in vaccination strategies in preparation for delivery of a Covid-19 vaccine
2019 Hosted Secretary of State for Wales at the Parliamentary Links day on ‘Science and the New Frontiers’ and discussed investment opportunities in Wales in precision and regenerative medicine for economic growth and specialist education/training
2018 Speaker at Pint of Science, ‘Immune cells: right place, right time’, Cardiff
2017 Speaker at Soapbox Science on 10th June 2017 in Cardiff showcasing women in Science (https://www.cardiff.ac.uk/news/view/798209-soapbox-science-cardiff-2017)
2017 Interactive practical demonstration of T cell trafficking at ‘Tackling Cancer Together’ open day organised by the Wales Cancer Partnership, Cardiff, 25th November 2017 (https://www.walescancerpartnership.com/partner-events/2017/11/25/tackling-cancer-together/)
2017-2020 Interviews about my research and career for Wales radio (https://radiocardiff.org/pythagoras-trousers/), Cancer Research UK website and BBC Television Wales
2016 Women’s Institute, Vale of Glamorgan: T-cells in immunity to viruses and cancers
2016 Wellcome Inspire team Taster Days to Medical and Dental Students year to educate, inform and inspire students about biomedical research
2014 Cancer Research UK Cardiff Centre Open Day: Presentation entitled ‘Of Mice and Men’ explaining translation of biomedical research to the clinic
2013 Speaker at Science in Health Live that hosts 500 Year 12 pupils from schools across Wales and the border counties "Directing the traffic; how to white blood cells know where to go?’. (https://vimeo.com/channels/312286/73863788). Student feedback included ‘The best part was the short talk about white blood cells as it helped to put more information onto what I have already learnt in school’